Search clinical trials for: BMS-512148

Total 3221 results

University of Valencia
University of Twente

Completed

Efficacy of a Positive Psychology Intervention Through a Mobile App

Not Flourishing Population

Spain, Netherlands
University Health Network, Toronto
The Lung Association

Completed

Effect of Electrical Muscle Stimulation in Critically Ill Patients

Critical Illness

Canada
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

United States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
Bristol-Myers Squibb

Completed

A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants

Healthy Participants

United States
Nektar Therapeutics
ImaginAb, Inc.

Withdrawn

A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab

Metastatic Melanoma

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

Healthy Volunteers

United Kingdom
Ascensia Diabetes Care

Completed

Evaluation of Blood Glucose Monitoring Systems

Diabetes

United States
MD Stem Cells

Recruiting

Neurologic Stem Cell Treatment Study (NEST)

Stroke | Nervous System Diseases | Diabetic Neuropathies | Neurodegenerative Diseases | Cognitive Impairment | Amyotrophic Lateral Sclerosis | Dementia | Neurological Disorders | Alzheimer Disease | ALS | Traumatic Brain Injury | Cerebral Infarction | Lewy Body Disease | Cerebral Hemorrhage | Frontotemporal Dementia | Progressive... and other conditions

United States, United Arab Emirates
Prof. Dr. Frank Mooren

Completed

Whole-body Electromyostimulation in Inpatient Rehabilitation (GERKO)

Sarcopenia

Germany
University of Erlangen-Nürnberg Medical School

Unknown

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases (FREEDOM)

Inflammation | Cancer | Muscular Atrophy | Cancer Cachexia

Germany
Andrew J. Armstrong, MD
Bristol-Myers Squibb

Recruiting

A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)

Metastatic Prostate Cancer | Metastatic Prostate Neuroendocrine Carcinoma

United States
Bristol-Myers Squibb

Active, not recruiting

Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)

Unresectable or Metastatic Melanoma

United States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
Spectrum Pharmaceuticals, Inc
Bayer

Completed

Zevalin Post-marketing Surveillance in Japan (ZEVALIN-DUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

Lymphoma, Follicular | Non-Hodgkin Lymphoma

Belgium
Bristol-Myers Squibb

Withdrawn

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Melanoma

United States
Bristol-Myers Squibb

Completed

A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

Healthy Volunteers

United States
Bristol-Myers Squibb

Completed

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Korea, Republic of, United States, Mexico, Spain, Russian Federation, South Africa, Argentina
Bristol-Myers Squibb

Completed

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Colorectal Cancer

United States, Canada, Netherlands
Bristol-Myers Squibb

Completed

Pharmacokinetics and Metabolism Study in Healthy Male Participants

Cancer

United States
HealthPartners Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrolling by invitation

Weight Loss Clinical Decision Support (BMI-CDS)

Obesity | Diabetes Mellitus, Type 2

United States
Zhongda Hospital

Completed

Effectiveness of Self-myofascial Release Combined With Biofeedback and Electrical Stimulation for the Management of MFPP

Myofascial Pelvic Pain

China
University of Minnesota

Completed

Brief Motivational Interviewing (BMI)

Motivational Interviewing, BMI, OHI

United States
Mackay Memorial Hospital

Terminated

Electric Muscle Stimulation for Patients With Chronic Respiratory Failure

Critical Illness Myopathy | Chronic Respiratory Failure

Taiwan
Nationwide Children's Hospital

Completed

Obesity Guidelines for Outpatient Surgery

Obesity

United States
AstraZeneca

Completed

To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects

Healthy
AstraZeneca

Completed

To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days

Healthy

United States
M.D. Anderson Cancer Center

Recruiting

Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression

Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent... and other conditions

United States
Bristol-Myers Squibb

Withdrawn

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

HIV Infections
University of Thessaly

Recruiting

The Impact of the Implementation of BIS on the Incidence of Postoperative Delirium

Postoperative Delirium

Greece
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery

Metastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland Pheochromocytoma

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Diabetes Type 2

United States, Canada, Korea, Republic of, Australia
Bristol-Myers Squibb

Completed

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B Infection

United States, Mexico, Puerto Rico, Brazil, South Africa
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Primary Care Clinical Practice Elements and Improving Overweight Children's Weight Status

Overweight | Childhood Obesity

United States
Bristol-Myers Squibb

Completed

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE)

Atrial Fibrillation | Atrial Flutter

Australia, Brazil, China, France, Germany, India, Italy, Korea, Republic of, Mexico, Russian Federation, Sweden, Taiwan, Turkey, United States, Hong Kong, Spain, Argentina, Canada, Puerto Rico, Colombia, Denmark, Austria, Belgium, Hun... and more
Bristol-Myers Squibb

Completed

Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects

Hepatitis C

United States
PharmatrophiX Inc.
National Institute on Aging (NIA)

Completed

Study of LM11A-31-BHS in Mild-moderate AD Patients

Mild to Moderate Alzheimer's Disease

Spain, Germany, Austria, Czechia, Sweden
Bristol-Myers Squibb

Completed

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy (STRUCTURE)

Hepatitis C

France, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Taiwan, United Kingdom, United States, Spain, Israel, Argentina, Poland
Ludwig-Maximilians - University of Munich
King's College London; University of Cambridge; Helmholtz Zentrum München; University...

Completed

Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease (BreathEase)

Cancer | Chronic Heart Failure | Interstitial Lung Disease | COPD | Breathlessness

Germany
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bristol-Myers Squibb; National Cancer Institute (NCI)

Recruiting

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
Lipocine Inc.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Liver Cirrhosis | Sarcopenia

United States
AstraZeneca

Completed

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Renal Impairment | Healthy Volunteers | Pharmacokinetics | Patients

United States
ASTORA Women's Health

Completed

Pelvic Floor Repair Systems for Prolapse Repair (PROPEL)

Pelvic Organ Prolapse

United States, Belgium, France, Germany, Netherlands, Spain, United Kingdom
The University of Hong Kong

Recruiting

Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema

Eczema | Dermatitis, Atopic

Hong Kong
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

Chronic Hepatitis C Infection

China
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg

Withdrawn

Effects of WB-EMS in Ulcerative Colitis Patients

Ulcerative Colitis

Germany
Cornerstone Pharmaceuticals

Withdrawn

Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
Bristol-Myers Squibb

Completed

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection

Hepatitis B, Chronic

United States, Korea, Republic of, Taiwan, United Kingdom, Brazil, Argentina, Belgium, Canada
Genentech, Inc.

Completed

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Spain, United States, France
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread (CheckMate142)

Microsatellite Stable Colorectal Cancer | Mismatch Repair Proficient Colorectal Cancer | Microsatellite Unstable Colorectal Cancer | Mismatch Repair Deficient Colorectal Cancer

United States, Australia, Belgium, Canada, Ireland, Italy, Spain, France
Bristol-Myers Squibb

Completed

Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma (CheckMate 066)

Melanoma

Canada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland

Search clinical trials for: BMS-512148

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations